July 17, 2025
Intangible Assets

Sun Pharma Shares Climb 3%, Leqselvi Settlement: Rediff Moneynews

Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a license for US patents and Leqselvi launch in the US market. New Delhi, Jul 15 (PTI) Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has

Read More
Intangible Assets

Sun Pharma launches alopecia drug Leqselvi in US after settling patent dispute

Sun Pharma on Monday announced it has settled a patent row with American biopharma company Incyte Corporation over its hair-loss drug, paving the way for its launch in the US. The Mumbai-based drugmaker, embroiled in the lawsuit since last year, launched the specialty drug in the world’s largest pharmaceutical market on Monday. Leqselvi (oral deuruxolitinib)

Read More